BEVARO 100 INJECTION 4 ML

BEVARO 100 INJECTION 4 ML is a recombinant monoclonal antibody that belongs to the immunotherapy class of cancer treatment. It can either be used as monotherapy or in combination with chemotherapy or immunotherapy medications to improve the overall survival rate.

While for women with reproductive potential subjected to BEVARO 100 INJECTION 4 ML, it is advised to discuss with your doctor regarding the effective birth control methods during the treatment. Also to be continued for a minimum of 6 months after the treatment course completion as this medicine may impair fertility.

BEVARO 100 INJECTION 4 ML is associated with increased risk of bleeding complications and poor wound healing. Hence it is suggested to avoid planning for surgery and maintain an interval of 28days before or after surgery.

All the side effects that are relatively caused by BEVARO 100 INJECTION 4 ML occur until the drug concentration stays in the body. It is found that this medicine will be contained in our body for almost 4 months after the final dose.

BEVARO 100 INJECTION 4 ML is given intravenously through infusion and the amount of drug will be measured based on the patient’s body weight, height and age. The first dose will be administered for 90 minutes and if well tolerated the infusion time can be reduced to 30 minutes.

Inform your physician before starting your treatment with BEVARO 100 INJECTION 4 ML in case, if you are pregnant or planning for pregnancy as this medicine may cause harm to the unborn baby and interrupt the formation of blood vessels.

There are no known significant negative interactions of BEVARO 100 INJECTION 4 ML with other drugs. However, it is always important to inform the doctor about all the medications you are taking to avoid any potential risks.

It is vital to inform your physician before taking BEVARO 100 INJECTION 4 ML if you have the following conditions: Have conditions involving inflammation in the stomach (ulcer, colitis). Experience allergic reactions to BEVARO 100 INJECTION 4 ML or its ingredients. Have recently undergone surgery as it is associated with the risk of bleeding. Have diabetes, hypertension, or heart problems.

The active ingredient in BEVARO 100 INJECTION 4 ML is bevacizumab, which is a monoclonal antibody.

BEVARO 100 INJECTION 4 ML is used to treat a variety of cancers, including colorectal cancer, lung cancer, breast cancer, glioblastoma, kidney cancer, and ovarian cancer.